Home
News
Create
Screeners
Insights
Parnax Lab
139.
00
-2.80
(-1.97%)
Market Cap
₹159.68 Cr
PE Ratio
13.81
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.97%
1M
+4.24%
6M
+17.65%
1Y
+8.47%
5Y
+440.86%
View Company Insights
Latest news about Parnax Lab
Parnax Lab seeks approval for director re-appointment
Jul 09, 2026
Parnax Lab Limited has commenced a postal ballot process to secure shareholder approval for the re-appointment of Mr. Yogesh Kantilal Varia as a Non-Executive Independent Director. The proposed tenure is five years, effective from May 28, 2026, to May 27, 2031. The remote e-voting period is scheduled from July 10, 2026, to August 8, 2026, with the cut-off date for voting rights set as July 3, 2026. M/s. MUFG Intime India Pvt. Ltd. is the e-voting agency, and HSPN & Associates LLP has been appointed as the scrutinizer.
Parnax Lab promoter acquires 3.15% stake via inter-se gift transfer
Jun 27, 2026
Parnax Lab reports FY26 net profit of ₹1,177.68 lakh
May 28, 2026
Parnax Lab board meets May 28 to consider Q4, FY26 results
May 20, 2026
Parnax Lab Ltd. Submits Quarterly Compliance Certificate for Q4 FY26 to BSE
Apr 08, 2026
More news about Parnax Lab
15
Feb 26
Parnax Lab Limited Reports Strong Q3FY26 Results with 56.45% Revenue Growth
Parnax Lab Limited announced robust Q3FY26 financial results with consolidated revenue from operations reaching ₹6,294.15 lakhs, marking a 56.45% year-on-year growth. The company's consolidated net profit surged 124.29% to ₹271.47 lakhs, while standalone operations showed even stronger growth with revenue increasing 174.58% to ₹270.82 lakhs and net profit jumping 349.43% to ₹70.91 lakhs.
Parnax Lab
139.
00
-
2.
80
(-
1.
97
%)
1 Year Returns:
+8.47%
Industry Peers
Sun Pharmaceutical
1,941.10
(-
0.
66
%)
Divis Laboratories
7,248.50
(-
0.
36
%)
Torrent Pharmaceuticals
4,961.50
(-
2.
05
%)
Cipla
1,410.60
(+
1.
26
%)
Zydus Life Science
1,108.70
(-
0.
37
%)
Lupin
2,370.50
(-
1.
08
%)
Mankind Pharma
2,507.20
(-
1.
96
%)
Dr Reddys Laboratories
1,151.70
(-
1.
25
%)
Aurobindo Pharma
1,532.00
(+
0.
56
%)
Laurus Labs
1,601.20
(+
2.
10
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar